Multi-institutional observational research of therapeutic evaluation with minimal residual disease(MRD) after consolidation for multiple myeloma
Not Applicable
- Conditions
- Multiple myeloma
- Registration Number
- JPRN-UMIN000032970
- Lead Sponsor
- Ochanomizu Hematology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who is judged to be medically unfit by physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The MRD negative rate by evaluating multiparameter flow cytometry(MFC) after consolidation therapy.
- Secondary Outcome Measures
Name Time Method